Pipobroman

Pipobroman
Clinical data
Trade names	Vercite, Vercyte
AHFS/Drugs.com	International Drug Names
ATC code	L01AX02 (WHO) ;
Identifiers
	IUPAC name 3-bromo-1-[4-(3-bromopropanoyl) piperazin-1-yl]-propan-1-one;
CAS Number	54-91-1;
PubChem CID	4842;
DrugBank	DB00236 ;
ChemSpider	4676 ;
UNII	6Q99RDT97R;
KEGG	D00467 ;
ChEMBL	ChEMBL1585 ;
CompTox Dashboard (EPA)	DTXSID7023485 ;
Chemical and physical data
Formula	C10H16Br2N2O2
Molar mass	356.054 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(N1CCN(C(=O)CCBr)CC1)CCBr;
	InChI InChI=1S/C10H16Br2N2O2/c11-3-1-9(15)13-5-7-14(8-6-13)10(16)2-4-12/h1-8H2 ; Key:NJBFOOCLYDNZJN-UHFFFAOYSA-N ;
	(verify)

Pipobroman (trade names Vercite, Vercyte) is an anti-cancer drug that probably acts as an alkylating agent.^[1] It is marketed by Abbott Laboratories.^[2]

References

^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.3109/10428190309178768, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with |doi=10.3109/10428190309178768 instead.
^ Drugs.com: Pipobroman

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.

[1] Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.3109/10428190309178768, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with |doi=10.3109/10428190309178768 instead.

[2] Drugs.com: Pipobroman

[1]

[2]